FDA Approvals - Ranbaxy Receives Tentative FDA Approval to Manufacture and Market Zolpidem
Ranbaxy Receives Tentative FDA Approval to Manufacture and Market Zolpidem Tablets (RedNova)
PRINCETON, N.J., March 16 /PRNewswire-FirstCall/ -- Ranbaxy Laboratories Limited (RLL), announced today that the Company has received tentative approval from the Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg. The Office of Generic Drugs, U.S.
Ranbaxy Receives Tentative FDA Approval to Manufacture and Market Zolpidem Tablets (PR Newswire via Yahoo! Finance)
Ranbaxy Laboratories Limited , announced today that the Company has received tentative approval from the Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg.